Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Pancreatic Ductal Adenocarcinoma × Immunotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasms 1 Melanoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Immunotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05955157 2024-01-10

Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma

University of Malaya

Phase 2/3 Unknown

GastrointestinalOther solid neoplasm

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡